Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lexeo Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LXEO.
You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.
Other companies in Lexeo Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Quoin Pharmaceuticals (NASDAQ:QNRX), Atossa Therapeutics (NASDAQ:ATOS) and Tango Therapeutics (NASDAQ:TNGX).
Lexeo Therapeutics has a consensus price target of $21.57.
The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $3.8077 last updated April 30, 2025 at 4:18 PM EDT.
There are no upcoming dividends for Lexeo Therapeutics.
Lexeo Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Lexeo Therapeutics.
Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.